RRD-21340-45992
3 vaccinations
1 coded response
13 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 550 / MN
- Registered
- 2021-09-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-20
Dose 1 — Pfizer-BioNTech
-
2021-05-11
Dose 2 — Pfizer-BioNTech
-
2021-09-02
Dose 3 — Pfizer-BioNTech
-
2021-09-04
Registered in v-safe
- 2021-09-05
-
2021-09-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-09-07
- 2021-09-08
- 2021-09-09
- 2021-09-16
-
2021-09-23
Survey response — day 21, dose 3MedDRA: Nasal congestion, Oropharyngeal pain — Feeling: FairFree text: Stuffy nose, sore throatMedDRA releases: 2024-11 · check-in free text available
- 2021-09-30
- 2021-10-07
- 2021-10-14
- 2021-12-02
- 2022-03-05
- 2022-09-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-20 | Pfizer-BioNTech | No |
| 2 | 2021-05-11 | Pfizer-BioNTech | No |
| 3 | 2021-09-02 | Pfizer-BioNTech | No |
Free text
Release 9 — day 21, dose 3
Symptoms: Stuffy nose, sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release